Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Mid-Cap · Horizon

Horizon Multi-Factor Small/Mid Cap Fund Advisor Class (HSMBX)

Ticker HSMBX · Since 2023-03-07 · · Holdings as of May 31, 2026

Expense ratio
1.24%$124/yr per $10k
1-yr return
+7.7%as of Dec 2025
Net assets
$748.9Mall share classes
Holdings
297

Bottom line

Is HSMBX a good fund? The bottom line

HSMBX is the Advisor Class share class of Horizon Multi-Factor Small/Mid Cap Fund, a managed mid-cap mutual fund from Horizon.

It charges 1.24% — about $124 a year on every $10,000 invested, more expensive than 80% of mid-cap funds we track.

It returned +7.7% over one year (as of Dec 31, 2025, per its prospectus).

With $749 million in net assets and 297 holdings, its largest position is TD SYNNEX Corp (1.9%) and the top 10 make up 14.5% of the portfolio.

What stands out

  • Broadly diversified (297 holdings)

What to watch

  • Expensive for its category (1.24%)
  • 12b-1 marketing fee of 0.25% a year
  • High turnover (146% a year) can mean more taxable distributions

Updated Nov 19, 2026

What HSMBX invests in

The investment objective of the Horizon Multi-Factor Small/Mid Cap Fund (the Multi-Factor Small/Mid Cap Fund or the Fund) is capital appreciation.

The Multi-Factor Small/Mid Cap Fund seeks to achieve its investment objective by investing primarily in the equity securities of small and mid-cap U.S. companies. In addition, the Fund employs defensive techniques, including strategic portfolio positioning, to achieve lower overall volatility as compared to the market generally. Horizon selects and weights securities using a flexible approach that combines active management and quantitative models to allocate the Funds portfolio between issuers, sectors and/or factors (e.g., growth, value, momentum, quality, size and volatility) that Horizon believes offer the opportunity for the highest projected return for a given amount of risk. Horizon assesses projected return and expected risk by diversifying across stocks that have one or more high quality underlying fundamentals, such as: high profitability and stable earnings; low price…

From the fund's prospectus (filed Jul 8, 2026).

HSMBX performance

Average annual total returns
1 yr5 yr10 yr
HSMBX+7.7%——
Mid-Cap median+7.9%+8.1%+9.9%

Source: Fund prospectus, as of Dec 31, 2025

Full HSMBX performance history →

What HSMBX costs

On a $10,000 investment, HSMBX's 1.24% expense ratio costs about $124 a year. The prospectus estimates $1,479 in total costs over 10 years (assuming 5% annual returns). The median mid-cap fund charges 0.88%.

See the full HSMBX fee table →

HSMBX top 10 holdings

#Holding% of fund
1TD SYNNEX Corp SNX1.91%
2Ovintiv Inc OVV1.62%
3United Therapeutics Corp UTHR1.60%
4Neurocrine Biosciences Inc NBIX1.42%
5Permian Resources Corp PR1.41%
6East West Bancorp Inc EWBC1.34%
7Mueller Industries Inc MLI1.33%
8HF Sinclair Corp DINO1.30%
9Reinsurance Group of America I RGA1.30%
10Twilio Inc TWLO1.27%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 14.5% of the fund. See all top 25 holdings and asset mix →

Alternatives to HSMBX

More funds like HSMBX →

HSMBX FAQ

What is the expense ratio of HSMBX?
HSMBX's expense ratio is 1.24%, which works out to about $124 a year for every $10,000 invested. The prospectus estimates total costs of $1,479 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is HSMBX a good investment?
It depends on your goals, but the data points to: broadly diversified (297 holdings); expensive for its category (1.24%); 12b-1 marketing fee of 0.25% a year; high turnover (146% a year) can mean more taxable distributions. This is general information, not personalized advice.
What does HSMBX hold?
HSMBX's largest holdings are TD SYNNEX Corp (1.9%), Ovintiv Inc (1.6%), United Therapeutics Corp (1.6%), Neurocrine Biosciences Inc (1.4%), Permian Resources Corp (1.4%). It holds 297 positions in total as of May 31, 2026 (SEC Form N-PORT).
Who manages HSMBX?
HSMBX is offered by Horizon through Horizon Funds.